Suppr超能文献

个性化医疗的里程碑:从古代到现代——新冠疫情的激发

Milestones in Personalized Medicine: From the Ancient Time to Nowadays-the Provocation of COVID-19.

作者信息

Visvikis-Siest Sophie, Theodoridou Danai, Kontoe Maria-Spyridoula, Kumar Satish, Marschler Michael

机构信息

Université de Lorraine, IGE-PCV, Nancy, France.

The Santorini Conferences (SCs) Association, Nancy, France.

出版信息

Front Genet. 2020 Nov 30;11:569175. doi: 10.3389/fgene.2020.569175. eCollection 2020.

Abstract

The first evidence of individual targeting medicine appeared in ancient times thousands of years ago. Various therapeutic approaches have been established since then. However, even nowadays, conventional therapies do not take into consideration individuals' idiosyncrasy and genetic make-up, failing thus to be effective in some cases. Over time, the necessity of a more precise and effective treatment resulted in the development of a scientific field currently known as "personalized medicine." The numerous technological breakthroughs in this field have acknowledged personalized medicine as the next generation of diagnosis and treatment. Although personalized medicine has attracted a lot of attention the last years, there are still several obstacles hindering its application in clinical practice. These limitations have come to light recently, due to the COVID-19 pandemic. This review describes the "journey" of personalized medicine over time, emphasizing on important milestones achieved through time. Starting from the treatment of malaria, as a first more personalized therapeutic approach, it highlights the need of new diagnostic tools and therapeutic regimens based on individuals' genetic background. Furthermore, it aims at raising global awareness regarding the current limitations and the necessity of a personalized strategy to overpass healthcare problems and hence, the current crisis.

摘要

个性化医疗的首个证据出现在数千年前的古代。从那时起,人们建立了各种治疗方法。然而,即使在当今,传统疗法也没有考虑个体的特质和基因构成,因此在某些情况下无法奏效。随着时间的推移,更精确、有效的治疗方法的必要性促使了一个目前被称为“个性化医疗”的科学领域的发展。该领域的众多技术突破使个性化医疗被公认为下一代诊断和治疗方法。尽管个性化医疗在过去几年中受到了广泛关注,但仍有几个障碍阻碍其在临床实践中的应用。由于新冠疫情,这些限制最近才被发现。本综述描述了个性化医疗随时间的“历程”,强调了随着时间推移所取得的重要里程碑。从作为首个更个性化治疗方法的疟疾治疗开始,它强调了基于个体基因背景的新诊断工具和治疗方案的必要性。此外,它旨在提高全球对当前限制以及采用个性化策略以克服医疗保健问题乃至当前危机的必要性的认识。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/443d/7794000/3dc1f0bfad4d/fgene-11-569175-g0001.jpg

相似文献

1
Milestones in Personalized Medicine: From the Ancient Time to Nowadays-the Provocation of COVID-19.
Front Genet. 2020 Nov 30;11:569175. doi: 10.3389/fgene.2020.569175. eCollection 2020.
2
[The origin of informed consent].
Acta Otorhinolaryngol Ital. 2005 Oct;25(5):312-27.
3
Future perspectives of personalized medicine in traditional Chinese medicine: a systems biology approach.
Complement Ther Med. 2012 Feb-Apr;20(1-2):93-9. doi: 10.1016/j.ctim.2011.10.007. Epub 2011 Nov 30.
4
Personalized medicine in breast cancer: pharmacogenomics approaches.
Pharmgenomics Pers Med. 2019 May 27;12:59-73. doi: 10.2147/PGPM.S167886. eCollection 2019.
6
Japan as the front-runner of super-aged societies: Perspectives from medicine and medical care in Japan.
Geriatr Gerontol Int. 2015 Jun;15(6):673-87. doi: 10.1111/ggi.12450. Epub 2015 Feb 5.
7
Towards personalized medicine for patients with autoimmune diseases: Opportunities and challenges.
Immunol Lett. 2017 Oct;190:130-138. doi: 10.1016/j.imlet.2017.08.002. Epub 2017 Aug 8.
8
Will "personalized medicine" need personalized laboratory approach?
Clin Chim Acta. 2009 Feb;400(1-2):25-9. doi: 10.1016/j.cca.2008.09.029. Epub 2008 Oct 8.
10
Clinical Applications of Personalized Medicine: A New Paradigm and Challenge.
Curr Pharm Biotechnol. 2017;18(3):194-203. doi: 10.2174/1389201018666170224105600.

引用本文的文献

1
Digital twin for personalized medicine development.
Front Digit Health. 2025 Aug 7;7:1583466. doi: 10.3389/fdgth.2025.1583466. eCollection 2025.
6
Volumetric printing and non-destructive drug quantification of water-soluble supramolecular hydrogels.
Drug Deliv Transl Res. 2025 Jun;15(6):2048-2063. doi: 10.1007/s13346-024-01723-6. Epub 2024 Oct 18.
7
Revolution in malaria detection: unveiling current breakthroughs and tomorrow's possibilities in biomarker innovation.
Ann Med Surg (Lond). 2024 Jul 17;86(10):5859-5876. doi: 10.1097/MS9.0000000000002383. eCollection 2024 Oct.
8
Bridging the Divide: A Review on the Implementation of Personalized Cancer Medicine.
J Pers Med. 2024 May 24;14(6):561. doi: 10.3390/jpm14060561.
9
The Roadmap toward Personalized Medicine: Challenges and Opportunities.
J Pers Med. 2024 May 21;14(6):546. doi: 10.3390/jpm14060546.

本文引用的文献

1
The network effect: studying COVID-19 pathology with the Human Cell Atlas.
Nat Rev Mol Cell Biol. 2020 Aug;21(8):415-416. doi: 10.1038/s41580-020-0267-3.
2
Do genetic polymorphisms in angiotensin converting enzyme 2 (ACE2) gene play a role in coronavirus disease 2019 (COVID-19)?
Clin Chem Lab Med. 2020 Jun 29;58(9):1415-1422. doi: 10.1515/cclm-2020-0727. Print 2020 Aug 27.
3
Genomewide Association Study of Severe Covid-19 with Respiratory Failure.
N Engl J Med. 2020 Oct 15;383(16):1522-1534. doi: 10.1056/NEJMoa2020283. Epub 2020 Jun 17.
4
Chloroquine or hydroxychloroquine for prophylaxis of COVID-19.
Lancet Infect Dis. 2020 Oct;20(10):1118. doi: 10.1016/S1473-3099(20)30296-6. Epub 2020 Apr 17.
5
Arbidol monotherapy is superior to lopinavir/ritonavir in treating COVID-19.
J Infect. 2020 Jul;81(1):e21-e23. doi: 10.1016/j.jinf.2020.03.060. Epub 2020 Apr 10.
6
Lopinavir-ritonavir in severe COVID-19.
Nat Med. 2020 Apr;26(4):465. doi: 10.1038/s41591-020-0849-9.
7
Tocilizumab treatment in COVID-19: A single center experience.
J Med Virol. 2020 Jul;92(7):814-818. doi: 10.1002/jmv.25801. Epub 2020 Apr 15.
8
Developing antibody tests for SARS-CoV-2.
Lancet. 2020 Apr 4;395(10230):1101-1102. doi: 10.1016/S0140-6736(20)30788-1.
9
Novel coronavirus treatment with ribavirin: Groundwork for an evaluation concerning COVID-19.
J Med Virol. 2020 Jul;92(7):740-746. doi: 10.1002/jmv.25798. Epub 2020 Apr 10.
10
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.
Int J Antimicrob Agents. 2020 Jul;56(1):105949. doi: 10.1016/j.ijantimicag.2020.105949. Epub 2020 Mar 20.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验